SEC ownership of PROKIDNEY CORP.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001850270.

Comparable stake leader

Tolerantia, LLC

Disclosed value leader

Control Empresarial de Capitales S.A. de C.V.

Comparable rows

50/50

Latest evidence

28 Apr 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Tolerantia, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
28 Apr 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001850270
Issuer location
Winston Salem, NC

Ownership snapshot

Top shareholders of PROKIDNEY CORP. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Tolerantia, LLC
Disclosed value leader
Control Empresarial de Ca...
Comparable rows
50/50
Latest evidence
28 Apr 2026
13D/G 3/4/5 13F Lead comparable stake: 36% 13D/G row: Tolerantia, LLC Showing 1-8 of 50 holder rows.

Quick read

Tolerantia, LLC leads the comparable SEC ownership view at 36%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Tolerantia, LLC's linked filing trail.
Comparable ownership Top 5
Tolerantia, LLC 36%
Control Empresarial de Capitales ... 36%
MORGAN STANLEY 6%
BlackRock, Inc. 1.4%
SUVRETTA CAPITAL MANAGEMENT, LLC 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Tolerantia, LLC
13D/G
36%
$93,004,165
106,901,339 shares
-$3,326,877 03 Jun 2025
Control Empresarial de Capitales S.A. de C.V.
13D/G 3/4/5
Other*, 10%+ Owner
36%
$132,052,942
73,842,723 shares
$0 28 Apr 2026
MORGAN STANLEY
13D/G 13F
Company
6%
$19,510,759
8,519,982 shares
$0 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
1.4%
from 13D/G
$2,482,938
1,387,116 shares
31 Mar 2026
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
6%
$22,090,866
12,341,266 shares
31 Mar 2026
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
1.1%
$4,066,123
2,271,577 shares
31 Mar 2026
Bleichroeder LP
13F
Company
13F
0.98%
$3,580,000
2,000,000 shares
31 Mar 2026
Artia Global Partners LP
13F
Company
13F
0.88%
$3,234,421
1,806,939 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$1,884,577.

Buys
$0
Insiders: 0
Sells
$1,884,577
Insiders: 1
Net
-$1,884,577
Shares: -757,162
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 757,162
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 757,162 $0 $1,884,577 -$1,884,577
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 26 reporting-owner rows connected to PROKIDNEY CORP.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
26
Largest Forms 3/4/5 holder
Legorreta G. Pablo
Net 12M change
-$1,884,577
Latest report
12 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Legorreta G. Pablo Director, 10%+ Owner $396,228,878 Mixed 28 May 2026
Control Empresarial de Capitales S.A. de C.V. Other*, 10%+ Owner $132,052,941 Median 28 Apr 2026
SC Master Holdings, LLC 10%+ Owner $17,374,357 Mixed 11 Jul 2022
Brian Jg Pereira Director $4,270,858 -$1,884,577 -31% Mixed 28 May 2026
Aaron Cowen 10%+ Owner $2,143,751 Mixed 11 Jul 2025
Todd C. Girolamo Chief Legal Officer $586,606 Median 12 Jun 2026
Darin J. Weber Chief Regulatory Officer $0 Mixed 01 Mar 2026
SCS Sponsor III LLC Former Director and 10% Owner Mixed 11 Jul 2022
John Maraganore Director Mixed 29 Jun 2023
William F. Doyle Director Mixed 28 May 2026
Libbie Parker McKenzie Chief Medical Officer Mixed 16 Jan 2023
Deepak Jain Chief Operating Officer Mixed 16 Jan 2023
James Coulston Chief Financial Officer Mixed 01 Mar 2026
Santos Jose Ignacio Jimenez Director Mixed 28 May 2026
Uma Sinha Director Mixed 28 May 2026
Bruce Culleton Chief Executive Officer, Director Mixed 01 Mar 2026
Kenneth Thomas Locke Chief Technical Officer Mixed 01 Jun 2026
Ulrich Peter Alfred Ernst EVP, Technical Operations Mixed 01 Apr 2024
Alan Lotvin Director Mixed 28 May 2026
Jennifer A. Fox Director Mixed 28 May 2026

Recent insider transactions for PROKIDNEY CORP.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Todd C. Girolamo PROK Class A Common Stock Conversion of derivative security 100% 163,857 327,713 12 Jun 2026 Direct
Todd C. Girolamo PROK Common Units in ProKidney Holdings, LLC Conversion of derivative security -100% -163,857 0 12 Jun 2026 Direct
Todd C. Girolamo PROK Class B Common Stock Conversion of derivative security -100% -163,857 0 12 Jun 2026 Direct
Alan Lotvin PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
Santos Jose Ignacio Jimenez PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
Jennifer A. Fox PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
William F. Doyle PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
Uma Sinha PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
Pablo G. Legorreta PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
Brian Jg Pereira PROK Director stock option (right to buy) Award 135,000 135,000 28 May 2026 Direct
Control Empresarial de Capitales S.A. de C.V. PROK Class A Common Shares (as defined in Exhibit 99.1 hereto) Conversion of derivative security 588.6% 63,118,645 73,842,723 28 Apr 2026 Direct
Control Empresarial de Capitales S.A. de C.V. PROK Common Units in ProKidney LLC Conversion of derivative security -100% -63,118,645 0 28 Apr 2026 Direct
Control Empresarial de Capitales S.A. de C.V. PROK Class B Common Shares Conversion of derivative security -100% -63,118,645 0 28 Apr 2026 Direct
James Coulston PROK Employee stock option (right to buy) Award 600,000 600,000 01 Mar 2026 Direct
Darin J. Weber PROK Employee stock option (right to buy) Award 400,000 400,000 01 Mar 2026 Direct
Todd C. Girolamo PROK Employee stock option (right to buy) Award 600,000 600,000 01 Mar 2026 Direct
Bruce Culleton PROK Employee stock option (right to buy) Award 3,000,000 3,000,000 01 Mar 2026 Direct
Brian Jg Pereira PROK Class A Common Stock Sale -100% $128,769 $2.37 -54,333 0 13 Nov 2025 Brian J. G. Pereira 2004 Trust
Brian Jg Pereira PROK Class A Common Stock Sale -100% $1,061,293 $2.37 -447,803 0 13 Nov 2025 By Brian J. G. Pereira 2012 Irrevocable Trust
Brian Jg Pereira PROK Class A Common Stock Sale -33.7% $75,152 $2.72 -27,595 54,333 12 Nov 2025 Brian J. G. Pereira 2004 Trust
Brian Jg Pereira PROK Class A Common Stock Sale -33.7% $619,363 $2.72 -227,431 447,803 12 Nov 2025 By Brian J. G. Pereira 2012 Irrevocable Trust
Darin J. Weber PROK Class A Common Stock Sale -100% -103,480 0 08 Jul 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .